Leroy M, Van Surell C, Pilliere R, Hagenmuller M P, Aegerter P, Raffestin B, Foucher A
Service d'Exploration Fonctionnelle Multidisciplinaire, Hôpital Ambroise Paré, Université René Descartes, Boulogne, France.
Hypertension. 1996 Dec;28(6):937-43. doi: 10.1161/01.hyp.28.6.937.
In normal subjects, the level and variability of blood pressure decrease during non-rapid eye movement (non-REM) sleep. In contrast, sleep apnea is associated with large swings in nocturnal pressure. In this study, we evaluated a computer-derived index of all-night blood pressure variability in normotensive snorers with or without sleep apnea. We also examined this index in snorers receiving medical treatment for coexistent ischemic heart disease. Beat-to-beat blood pressure was recorded with a photoplethysmographic device (Finapres) throughout polysomnography. Subjects were categorized into four groups: those without cardiovascular disease without or with sleep apnea (> or = 15 apnea plus hypopnea per hour of sleep), and those with ischemic heart disease without or with sleep apnea. A frequency distribution histogram of all increases and decreases of blood pressure according to their amplitudes was drawn and the SD of the distribution used as an estimation of variability. Mean systolic and diastolic pressures during the total sleep time were not different among the four groups. In contrast, the SD of the distribution of systolic and diastolic pressure variations that were higher in the apneic than in the nonapneic groups (P < .05) correlated with apnea plus hypopnea (P < .0001) and transient electroencephalographic arousal number per hour of sleep (P < .0001). In both apneic and nonapneic subjects, blood pressure variability as assessed by SD decreased during stages 3 and 4 of non-REM sleep compared with stages 1 and 2 and REM sleep (P < .001). Blood pressure variability was similarly increased in apneic subjects with or without ischemic heart disease. We speculate that in apneic individuals with coexistent ischemic heart disease, pressure variability that is increased despite treatment with beta-blockers or calcium antagonists may be a risk factor for acute coronary events.
在正常受试者中,非快速眼动(non-REM)睡眠期间血压水平及变异性降低。相比之下,睡眠呼吸暂停与夜间血压大幅波动有关。在本研究中,我们评估了有或无睡眠呼吸暂停的血压正常打鼾者全夜血压变异性的计算机衍生指数。我们还在因并存缺血性心脏病而接受药物治疗的打鼾者中检测了该指数。在整个多导睡眠图监测过程中,使用光电容积描记装置(Finapres)记录逐搏血压。受试者被分为四组:无心血管疾病且无或有睡眠呼吸暂停(每小时睡眠中呼吸暂停加呼吸不足>或 = 15次)的患者,以及有缺血性心脏病且无或有睡眠呼吸暂停的患者。根据血压升降幅度绘制所有血压升降的频率分布直方图,并将该分布的标准差用作变异性的估计值。四组患者总睡眠时间内的平均收缩压和舒张压无差异。相比之下,呼吸暂停组收缩压和舒张压变化分布的标准差高于非呼吸暂停组(P <.05),且与呼吸暂停加呼吸不足(P <.0001)以及每小时睡眠中短暂脑电图觉醒次数(P <.0001)相关。在呼吸暂停和非呼吸暂停受试者中,与非快速眼动睡眠的第1和第2阶段以及快速眼动睡眠相比,非快速眼动睡眠第3和第4阶段通过标准差评估的血压变异性降低(P <.001)。有或无缺血性心脏病的呼吸暂停受试者的血压变异性同样增加。我们推测,在并存缺血性心脏病的呼吸暂停个体中,尽管使用了β受体阻滞剂或钙拮抗剂进行治疗,但血压变异性增加可能是急性冠状动脉事件的一个危险因素。